Studies in lung cancer models have also shown that other specific chemotherapy regimens lead to increased CD8 T cell infiltration due to immunogenic cell death (ICD), which is known to increase inflammation and tumor antigen presentation in the tumor (23). This evidence concerns the gene CD8A and lung carcinoma.